Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett ...

FDA Drug Recall #D-0599-2025 — Class II — August 11, 2025

Recall Summary

Recall Number D-0599-2025
Classification Class II — Moderate risk
Date Initiated August 11, 2025
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Lannett Company Inc.
Location Seymour, IN
Product Type Drugs
Quantity 8544 bottles

Product Description

Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37

Reason for Recall

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Distribution Pattern

Nationwide within the USA

Lot / Code Information

Lot #: 25280726A, Exp. Date 03/2027

Other Recalls from Lannett Company Inc.

Recall # Classification Product Date
D-0584-2026 Class II Niacin Extended-release Tablets, USP, 1,000 mg,... May 27, 2026
D-0533-2026 Class III Primidone Tablets USP, 250mg, 100-count bottle,... Apr 24, 2026
D-0096-2026 Class II Niacin Extended-release Tablets, USP, 1,000 mg,... Oct 10, 2025
D-0642-2025 Class II Dextroamphetamine Saccharate, Amphetamine Aspar... Aug 19, 2025
D-0112-2025 Class II Lisdexamfetamine Dimesylate Capsules, 10 mg, 10... Oct 25, 2024

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.